Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 1.14% | 33.84 | 0.9% | $1138.25m | |
| JNJ | Johnson & Johnson | 0.01% | 142.50 | 0.7% | $1016.34m | |
| BMY | Bristol-Myers Squibb Co. | -1.17% | 57.43 | 1.0% | $922.01m | |
| MRK | Merck & Co., Inc. | 0.05% | 76.73 | 0.7% | $787.68m | |
| ABBV | AbbVie, Inc. | -1.18% | 96.78 | 1.9% | $725.30m | |
| LLY | Eli Lilly & Co. | -1.84% | 163.39 | 1.1% | $641.93m | |
| AZN | AstraZeneca Plc | -0.40% | 53.76 | 1.2% | $288.49m | |
| RPRX | Royalty Pharma Plc | -1.49% | 47.64 | 0.1% | $203.76m | |
| NVS | Novartis AG | -0.36% | 87.03 | 0.2% | $143.34m | |
| RGEN | Repligen Corp. | -1.97% | 126.13 | 7.1% | $115.34m | |
| GSK | GlaxoSmithKline Plc | -1.14% | 39.91 | 0.2% | $109.88m | |
| NVO | Novo Nordisk A/S | -0.26% | 65.44 | 0.1% | $88.47m | |
| RETA | Reata Pharmaceuticals, Inc. | -1.10% | 154.40 | 3.4% | $79.42m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | -2.31% | 74.14 | 0.0% | $67.56m | |
| SNY | Sanofi | -0.53% | 50.28 | 0.2% | $63.74m |
Company Profile
Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It operates through the Prescription Pharmaceuticals and Consumer Health business segments. The Prescription Pharmaceuticals segment manufactures and markets generic and branded prescription pharmaceuticals including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The Consumer Health segment offers branded and private-label animal health; and over-the-counter products. The company was founded in 1971 and is headquartered in Lake Forest, IL.